title: Targeting endostatin to potentially prevent retinal neovascularization using a hypoxia-responsive Müller glia cell-specific gene therapy.
authors.affiliation: Mary D. Allen Laboratory for Vision Research, Department of Ophthalmology and Cell & Neurobiology, Keck School of Medicine of the University of Southern California, USC Eye Institute, Los Angeles, California, United States; ccraft@usc.edu.
authors.forename: Cheryl Mae
authors.initials: CM
authors.lastname: Craft
mesh_terms: D000818:Animals; D015687:Cell Hypoxia / Q000502:physiology*; D003930:Diabetic Retinopathy / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D009457:Neuroglia / Q000502:physiology*; D015861:Retinal Neovascularization / Q000628:therapy*